Pages

Powered by Blogger.
Showing posts with label Market-Research-Reports. Show all posts
Showing posts with label Market-Research-Reports. Show all posts

Friday, 21 June 2013

Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018

Immunoprotein Diagnostic Testing Market
Diagnostic testing market is growing rapidly with increasing number of diseases such as anemia, rheumatoid arthritis, multiple myeloma, allergy. infections, heart related diseases, liver and kidney diseases and advancements in technology. Immunoprotein diagnostic testing market includes reagents, diagnostic test products, instrumentation and other auxiliary products required to perform a diagnostic test.

Browse Report : http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html

C3, C4, free light chain, haptoglobin, IgA, IgE, IgG, IgM, immunofixation, prealbumin, protein electrophoresis are the major immunoproteins used in diagnostic testing. Haptoglobin test is performed to identify the level of haptoglobin to confirm the presence of diseases sucha as peptic ulcer, biliary obstruction and chronic liver diseases. Protein electrophoresis and immunofixation are used to find out the presence of abnormal proteins to confirm multiple myeloma, multiple sclerosis, cirrhosis and rheumatoid arthritis, IgE test are carried out to detect allergies.

Various diagnostic tools available in the market for immunoprotein testing are Abaxis Piccolo, which is able to accomplish a test in 12 minutes, Abbott AxSYM is used for serology test and to monitor therapeutic drug level, AMS Liasys is able to perform 450 tests per hour. Others include Beckman Coulter Access, Binding Site ESP600, DiaSorin Liaison, J&J DT System, Randox RX Daytona, Siemens Immulite and Roche Cardiac 200.
Immunoprotein diagnostic testing market can be segmented on the basis of major types of immunoproteins such as C3, C4, free light chain, immunoglobulins, and haptoglobin. Major growth drivers for this immunoprotein testing market are demand for latest tests and technology, increasing number of hospitals and labs are seeking to expand their diagnostic capacity and intense competition among market players. Apart from these growth factors, few factors may hinder the market growth as well such as entry barriers in few countries such as china, cost containment,

Some of the major players in this market are Roche, Abbott Laboratories, AdnaGen, Agilent Technologies, Biomedical Diagnostics, Bio-Rad, and Bio Merieux.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments 
Browse Blog : Transparency Market Research

Thursday, 20 June 2013

Orphan Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2012 - 2018

Orphan drugs are specific pharmaceutical agents which are developed for treatment of orphan or rare diseases. Orphan disease, according to laws of various countries, may include medical conditions which have low prevalence, i.e. affects less than 200,000 persons (U.S.), or 50,000 (Japan). Expiring patents of blockbuster drugs, drying pipelines, stringent regulations across the globe, has encouraged the pharmaceutical industries to shift the focus to a new business model that includes niche busters or orphan drugs.

Browse Report : http://www.transparencymarketresearch.com/orphan-drugs-market.html

Currently, around 7,000 diseases are recognized as orphan and around 250 new diseases are added to the list every year. Orphan drug laws introduced and implemented in countries such as the U.S., Japan, Singapore, Australia, and the European Union, have stimulated the orphan drug market and shifted the focus of pharmaceutical companies towards incentives on developing orphan drugs. The orphan drugs market currently forms around six percent of the total pharmaceutical market. However, this market is expected to register double digit growth to outshine the mainstream drugs market in the near future.

Orphan drugs market will be driven by the R&D benefits or grants availed, FDA fee waiver benefits, and shorter development timelines along with favorable reimbursement, prolonged exclusivity, premium pricing and fewer hurdles for getting approval of the drug. However, the market confronts the challenge of locating or recruiting patient for trials. Nevertheless, the orphan drug market is expected to maintain a competitive edge over the traditional drug model.

Some of the major players in the orphan drug market include Pfizer, Genentech, Abbott Laboratories, Amgen, Inc., Sanofi Aventis, Janssen Biotech, Inc. among others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
http://www.transparencymarketresearch.com/latest.php?type=U

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Browse Blog : Transparency Market Research Reports

http://tmrmarketresearch.wordpress.com/

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments 

Monday, 10 June 2013

Seed Treatment Market is Expected to Reach USD 4.45 Billion in 2018: Transparency-Market-Research.com

According to a new market report published by Transparency Market Research "Seed Treatment (Insecticides, Fungicides, Other Chemical and Nonchemical Treatment) Market For Corn, Soybean, Wheat, Canola, Cotton and Others - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018,"  the global seed treatment market was valued at USD 2.43 billion in 2011 and is expected to reach USD 4.45 billion by 2018, growing at a CAGR of 9.2% from 2012 to 2018.

Browse the full report at http://www.transparencymarketresearch.com/seed-treatment-market.html

The global demand of seed treatment has been primarily driven by the growth of the commercial seeds (conventional and bio-seeds) market. Increasing global farming and reduction in arable land has generated the need for high yield productivity, further boosting the market for seed treatment. Increasing input cost of seeds and technological developments in agriculture are also expected to drive the demand for seed treatment. However, environmental concerns regarding the toxicity of chemicals used in insecticides, fungicides and other chemical treatments are expected to inhibit the market growth.

Insecticides dominated the seed treatment market and accounted for 52.5% of the total market revenue in 2011. Insecticides were followed by fungicides which accounted for 34.9% of the total market in 2011. Nonchemical treatment, which is generally done using biological agents, is expected to be the fastest growing treatment, at an estimated CAGR of 9.9% from 2012 to 2018.

Corn was the most dominant crop for seed treatment, accounting for 34.7% of the global revenues in 2011. Corn was followed by soybean, wheat canola and cotton. Canola is expected to be the fastest growing crop requiring seed treatment, at a CAGR of 9.6% from 2012 to 2018.

Browse all Chemical Industry Research Reports @ http://www.transparencymarketresearch.com/chemical-market-reports-2.html

North America was the leading market for seed treatment and accounted for 42.8% of the global market in 2011; North Americawas followed by Latin America sharing 24.2% of the global market for the same year. Asia Pacific is expected to be the fastest growing market for seed treatment at a CAGR of 10.2% from 2012 to 2018. Growing awareness regarding the advantages of treating seeds coupled with government initiatives in countries such as China and India is expected to drive the seed treatment demand in Asia Pacific.

The global market for seed treatment is highly concentrated with the top four companies accounting for more than 80% of the total market in 2011. Syngenta and Bayer CropScience together accounted for more than 60% of the total market in 2011. Some of the other companies operating in the global seed treatment market include Monsanto, BASF Agriculture Solutions, DuPont, Chemtura, Nufarm etc.

The report segments the global seed treatment market as:
Seed Treatment Market: Treatment Type Analysis
Seed Treatment Market: Crop Type Analysis
Seed Treatment Market: Regional Analysis

About Us

TransparencyMarket Researchis a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com